Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.800
+0.004 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
0.732
-0.068 (-8.50%)
After-hours: Mar 9, 2026, 6:48 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $18.47 million as of March 9, 2026. Its market cap has increased by 980.49% in one year.
Market Cap
18.47M
Enterprise Value
13.96M
1-Year Change
980.49%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $18.47M, a decrease of -71.71%. That is a compound annual growth rate of -24.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 18.39M | -38.26% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |
| VYNE Therapeutics | 19.83M |
| Cadrenal Therapeutics | 19.36M |